PLAAT5: A Drug Target / Disease Biomarker (G117245)

Target Name: PLAAT5

NCBI ID: G117245

PLAAT5

PLAAT5: A Drug Target / Disease Biomarker

PLAAT5 is a protein that is expressed in various tissues throughout the body, including the brain, pancreas, and muscle. It is a key player in the regulation of cellular processes that are essential to the function of these organs, and is potential drug target for various diseases.

PLAAT5 is involved in a number of cellular processes that are critical to the development and maintenance of tissues. For example, it plays a role in the regulation of cell division, which is essential for the growth and development of tissues. It also helps to maintain the structure and function of the blood vessels, which are critical for delivering oxygen and nutrients to tissues and for removing waste products.

In addition to its role in cellular processes, PLAAT5 is also involved in the regulation of various signaling pathways that are critical to the function of tissues. For example, it is involved in the regulation of the DNA damage response, which is critical for the maintenance of cellular health and is important for the development and treatment of various diseases.

PLAAT5 is also expressed in various tissues and is involved in the regulation of a wide range of cellular processes that are important for tissue function and development. It is potential drug target for various diseases, including cancer, neurodegenerative diseases, and cardiovascular diseases.

The potential utility of PLAAT5 as a drug target is due to its involvement in a wide range of cellular processes that are important for the function of tissues. Its role in the regulation of cell division, blood vessel structure and function, and cellular signaling pathways suggests that it may be a useful target for diseases that are characterized by the disruption of these processes.

PLAAT5 is also a good candidate for a biomarker for certain diseases. Its expression in various tissues and its involvement in a wide range of cellular processes make it a potential indicator of disease. This suggests that it may be a useful biomarker for diseases that are characterized by the disruption of cellular processes.

In conclusion, PLAAT5 is a protein that is involved in a wide range of cellular processes that are critical to the function of various tissues. Its potential as a drug target and as a biomarker makes it an attractive target for the development of new treatments for a wide range of diseases. Further research is needed to fully understand its role in cellular processes and its potential as a drug and biomarker.

Protein Name: Phospholipase A And Acyltransferase 5

Functions: Exhibits both phospholipase A1/2 and acyltransferase activities (PubMed:22825852, PubMed:26503625). Shows phospholipase A1 (PLA1) and A2 (PLA2) activity, catalyzing the calcium-independent release of fatty acids from the sn-1 or sn-2 position of glycerophospholipids (PubMed:22825852). Shows N-acyltransferase activity, catalyzing the calcium-independent transfer of a fatty acyl group at the sn-1 position of phosphatidylcholine (PC) and other glycerophospholipids to the primary amine of phosphatidylethanolamine (PE), forming N-acylphosphatidylethanolamine (NAPE), which serves as precursor for N-acylethanolamines (NAEs) (PubMed:19000777, PubMed:22825852)

The "PLAAT5 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about PLAAT5 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets